Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

257 (7%)

Anticipated shortage:

3 (0%)

Avoided shortage:

11 (0%)

Resolved:

3300 (92%)

3571

Discontinuation Reports

To be discontinued:

24 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

366

143 (4%)

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMOXI PWR FOR SUSP 250MG/5ML 250MG POWDER FOR SUSPENSION Resolved 2019-01-03 2019-02-01 71103
APO-AMOXI PWR FOR SUSP 250MG/5ML 250MG POWDER FOR SUSPENSION Resolved 2018-03-27 2018-04-24 44099
APO-AMOXI PWR FOR SUSP 250MG/5ML 250MG POWDER FOR SUSPENSION Resolved 2017-11-13 2018-01-31 29028
APO-AMPHETAMINE XR 5MG CAPSULE (EXTENDED RELEASE) Resolved 2025-02-13 2025-07-25 250325
APO-AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-23 2023-03-23 179437
APO-AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2025-04-24 2025-07-25 255716
APO-AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2025-08-07 2025-11-15 264567
APO-AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2023-09-22 2023-11-17 204987
APO-AMPHETAMINE XR 5MG CAPSULE (EXTENDED RELEASE) Resolved 2024-01-19 2024-02-23 216681
APO-AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2023-02-23 2023-03-23 185474
APO-AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2025-08-07 2025-11-19 264564
APO-AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2025-08-07 2025-11-21 264573
APO-AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2024-01-12 2024-03-01 215964
APO-AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2025-08-07 2025-11-19 264570
APO-AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2025-02-27 2025-07-25 251358
APO-AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2025-01-30 2025-07-25 249092
APO-AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Resolved 2025-08-07 2025-11-15 264576
APO-AMPHETAMINE XR 5MG CAPSULE (EXTENDED RELEASE) Resolved 2025-08-07 2025-11-19 264561
APO-AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2023-02-09 2023-04-06 184103
APO-AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2025-02-27 2025-07-25 251361
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110968
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971
APO-HYDROMORPHONE CR 4.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110974
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROXYQUINE 200MG TABLET Discontinued 2018-09-07 2018-10-05 60524
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-IRBESARTAN 150MG TABLET Discontinued 2018-09-07 2018-12-28 60536
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-IRBESARTAN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60539
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40769
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-07-17 40760
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40766
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557